LGALS9 and hepatocellular carcinoma: In multivariate analysis, both intra-tumoral Gal-9 (p = 0.003) and circulating Gal-9 (p = 0.031) independently predicted HCC-specific survival, together with the presence of cirrhosis (p = 0.036) and AFP > 100 μgl−1 (p = 0.050).